SCHEMBL13487607

SCHEMBL13487607

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4cnc5ccccc5n4)c4ccc(-c5cccc6ccccc56)cc34)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.36
RAB9A P51151 7/20 0.36
JAK2 O60674 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
BCHE P06276 1/20 0.33
MET P08581 1/20 0.32
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TGFBR1 P36897 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 2/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK10 P53779 1/20 0.32
ATM Q13315 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487984 0.95 NPC1 (0.36) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487773 0.91 NPC1 (0.38) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487668 0.90 NPC1 (0.36) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487519 0.90 NPC1 (0.37) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487179 0.89 NPC1 (0.36) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487452 0.88 NPC1 (0.39) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487597 0.88 NPC1 (0.34) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL13488135 0.88 NPC1 (0.40) NPC1RAB9AJAK2SMN1; SMN2BCHE
SCHEMBL13487621 0.87 ACACA (0.39) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL13487594 0.86 HTR2C (0.41) NPC1SMN1; SMN2MAPTKDM4ETGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NPC1 1139/4885RAB9A 3244/4885JAK2 4147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.